Ignite Creation Date:
2025-12-24 @ 12:14 PM
Ignite Modification Date:
2026-01-04 @ 1:10 AM
Study NCT ID:
NCT00196261
Status:
COMPLETED
Last Update Posted:
2018-03-12
First Post:
2005-09-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction
Sponsor:
Deutsches Herzzentrum Muenchen
Organization:
Study Overview
Official Title:
Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the performance of established and new risk preditors in predicting long term-mortality (up to ten years) of post-infarction patients.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: